NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for MGYR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS reaches at least $0.99 in 2026-Q3 | A supporting condition in MAGYAR BANCORP INC's published investment case. The stated target is >=0.99 USD per share. | Broken | EPS guidance falls below $0.77 (2025-Q3 actual EPS) for 2026-Q3 | Diluted EPS: $0.49 per share FY2026-Q3; GAAP. Published target: >=0.99 USD per share. Target period ends 2026-09-30; this observation covers 2026-Q3. Aug 13, 20260.49 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
MGYR is a smaller-cap financial company with a recent earnings-growth and margin-improvement case. Its long-term thesis is intact, but risk is elevated and earnings quality and management are rated neutral.
The valuation evidence points to MGYR being cheap versus peers, and the priced-in assessment is tagged justified with low fragility. The expectations gap is negative, while the valuation score recently fell by 14 points; the snapshot does not explain what specific expectations the market assumes.
Near-term, the latest quarter showed net income up 31% year over year and net interest margin rising from 3.47% to 3.84%, consistent with management’s focus on loan growth and margin management. Cost progress is less clear: full-year non-interest expenses rose to $22.0 million from $21.4 million, and savings from the Edison move were not quantified. The snapshot flags a 31% miss probability and notes recent misses, despite a quiet risk tier.
Near-term, a guidance cut at the next call would be a meaningful negative, while the snapshot also identifies rate cuts from the current 3.88% as a sector headwind. Over the multi-year view, continued earnings growth and margin management matter, alongside clearer expense control; stronger earnings and guidance from sector bellwethers could support sector momentum.
Over the next 1 to 3 years, the thesis rests on sustaining recent earnings and margin progress while improving cost control. The latest results support an intact view, but smaller-cap risk and the possibility of weaker guidance remain important. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Net income increased from $2.47M to $3.03M in the same period. |
| Intact |
| net income falls below $2.47M in any quarter through 2026-Q2 |
Net income: $3.093M FY2026-Q3; GAAP. Published target: >=3030000 USD. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Aug 13, 20263,093,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating income increases to at least $4.27M by 2026-Q2 | Operating income rose from $3.47M to $4.27M in under a year. | Intact | operating income falls below $3.47M in any quarter through 2026-Q2 | Operating income: $4.353M FY2026-Q3; GAAP. Published target: >=4268000 USD. The stored target says 2026-Q2; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Aug 13, 20264,353,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.